[Which alpha/beta ratio for prostate cancer in 2019?] En savoir plus sur [Which alpha/beta ratio for prostate cancer in 2019?]
[Reirradiations: Which decision-making criteria?] En savoir plus sur [Reirradiations: Which decision-making criteria?]
Is there any benefit to particles over photon radiotherapy? En savoir plus sur Is there any benefit to particles over photon radiotherapy?
\"Real-world\" evaluation of <sup>18</sup>F-Choline PET/CT practices in prostate cancer patients and impact on changes in therapeutic strategy. En savoir plus sur \"Real-world\" evaluation of 18F-Choline PET/CT practices in prostate cancer patients and impact on changes in therapeutic strategy.
Can Comprehensive Geriatric Assessment Predict Tolerance of Radiotherapy for Localized Prostate Cancer in Men Aged 75 Years or Older? En savoir plus sur Can Comprehensive Geriatric Assessment Predict Tolerance of Radiotherapy for Localized Prostate Cancer in Men Aged 75 Years or Older?
Brain metastasis formation and irradiation by stereotactic radiation therapy combined with immunotherapy: A systematic review. En savoir plus sur Brain metastasis formation and irradiation by stereotactic radiation therapy combined with immunotherapy: A systematic review.
Drastic Reduction of Turnaround Time After Implementation of a Fully Automated Assay for RAS-BRAF Mutations in Colorectal Cancer: A Pilot Prospective Study in Real-life Conditions. En savoir plus sur Drastic Reduction of Turnaround Time After Implementation of a Fully Automated Assay for RAS-BRAF Mutations in Colorectal Cancer: A Pilot Prospective Study in Real-life Conditions.
Targeting DNA repair in combination with radiotherapy in pancreatic cancer: A systematic review of preclinical studies. En savoir plus sur Targeting DNA repair in combination with radiotherapy in pancreatic cancer: A systematic review of preclinical studies.
[Nomadism of patients treated by radiotherapy in Île-de-France: Does our health system have as much money to waste?] En savoir plus sur [Nomadism of patients treated by radiotherapy in Île-de-France: Does our health system have as much money to waste?]
Patterns of practice of androgen deprivation therapy combined to radiotherapy in favorable and unfavorable intermediate risk prostate cancer. Results of The PROACT Survey from the French GETUG Radiation Oncology group. En savoir plus sur Patterns of practice of androgen deprivation therapy combined to radiotherapy in favorable and unfavorable intermediate risk prostate cancer. Results of The PROACT Survey from the French GETUG Radiation Oncology group.